The session includes a live Q&A, providing actionable insights to help clinicians support informed decision-making. Stay informed with this recorded webinar on the evolving field of psychedelic medicine. “Our workshops and webinar provide an opportunity for veterinary professionals to come together, who might not otherwise get the chance to do so.” The workshops will take place both in-person and online and will be held for designated groups of the veterinary community – for example, vets in both clinical and non-clinical roles, veterinary nurses, those working in the not for profit sector, and new to management professionals – throughout March, April, May and June.
#MHForAll Webinar: Breaking Barriers – Reclaiming ‘mad activism’, shifting power and centring lived experience
And you are more than welcome to visit the Wellcome Trust website, look at the full webinar where Dr. Pim Cuijpers and Mark van Ommeren presented the details on how they look at stratification and what are different approaches and methodologies. I will be just presenting the part that is about the funding goal so you can know what are we looking for in our funding goal and put together the application. This webinar was recorded by us a week ago, and Professor Pim Cuijpers and Dr. Mark van Ommeren from WHO were the panelists, along with our Wellcome Trust team. So the purpose of the talk by Wesley was to actually help you imagine the process and know the resources where you can go. This is our website which we are developing for further information and some interactive data. We have reached that now, and to our surprise and happiness as well, this is an analysis of how many of those at high risk converted depression three years later to the low risk, and the score worked and we have a risk ratio of around four between those groups.
Connect with TriNetX
There are other scores that I know for schizophrenia and other mental health outcomes. But there’s a lot of ways to measure predictions, there’s calibration, a lot of different ways of measuring how well you can predict mental health outcomes. For you, Arthur, how predictable are these mental health illnesses, in your opinion?
So we began with one movie, Back to the Future, and we went to the cohorts and looked at the data collected many years ago to predict an outcome years later. What we wanted to do next was to use this cohort to identify those at high and low risk and gain insights about biomarkers using the separation between low and high risk. What we have been doing after we developed in Brazil, we went to several other cohorts around the world and applied the same model without any adjustments to new unseen data in the United Kingdom, New Zealand, Nepal, Nigeria, USA and the second cohort in Brazil. We published this first risk score generated in Brazil with an area under the curve of 77 percent.
The diversity of speakers on the webinars has brought up fascinating conversations, and comparisons, of cross-setting adaptations and innovations. Studies show that over the past year, mental health conditions have doubled, or even tripled in many parts of the world. Thousands more have read the notes and watched the recordings of the webinars. Usman Hamdani, Ph.D., is the Research Lead in the Mental Health Translation team at Wellcome Trust, where he leads the portfolio of non-pharmacological interventions and stratification in mental health Trauma-informed school programs for youth research. He has also collaborated with UNICEF’s State of the World’s Children Report specifically to discuss risk factors for child and adolescent mental disorders worldwide. Lynsey Bilsland, Ph.D., is Head of the Mental Health Translation team at Wellcome Trust, which aims to develop a portfolio of funded projects that enable identification, prediction, and early intervention in mental health problems.
- Data is sourced directly from our growing global network of over 8,000 healthcare provider locations.
- Please select your profession in order to view a drop down menu of applicable course selections.
- Dr. Mehul Mankad is Chief Medical Officer of NovumHealth, a behavioral health company serving individuals in Arizona, Nevada, and California.
- We need objective markers that can help us classify these people into subgroups so that we can intervene and provide the right treatment to the right person at the right time.
The first is that we are only limited to those individuals who have a family history in the first place, and the second is that we know that family risk gives us very low relative risk in general — two, three to five maybe in the case of depression. In the case of depression and many other disorders I think the most relevantly used marker of risk is family history, but there’s a lot of limitations with that. Or we can use predictive models to find those who are at risk even when they don’t have any symptoms. I think this has been the main approach, for instance, for schizophrenia in high-risk individuals that have sub-threshold symptoms. So we have (audio drop) one is indicated, so those that have minimal but detectable signs or symptoms that foreshadow a future mental disorder. We have selective and indicated in the promotion of health.
Here you’ll find our wide range of free webinars, covering COVID-19 and many other topics. This webinar series, co-sponsored by the UCSF Department of Psychiatry and Behavioral Sciences, UCSF Office of Alumni Relations, Greater Good Science Center at UC Berkeley, Mindsight Institute, and the John W. Brick Mental Health Foundation, was held in the spring of 2020. This webinar series for UCSF staff is co-sponsored by the UCSF Department of Psychiatry and Behavioral Sciences, UCSF Staff Assembly, UCSF Administrative Management Professionals, Diversity & Inclusion Certificate Program Alumni, and Council on Campus Climate, Culture and Inclusion (4CI) Staff Subcommittee. The climate crisis is impacting health, and health care professionals have a pivotal role as advocates for change.
Nejnovější komentáře